Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response

Wen Tong(Tianjin First Center Hospital), Yamin Zhang(Nankai University), Hao Wu(Tianjin First Center Hospital), Yi Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Long Yang(Shanghai Medical College of Fudan University), Tao Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Liuyang Zhu(Tianjin First Center Hospital), Guangyu Wang(Tongji University), Zirong Liu(Tianjin First Center Hospital)
Frontiers in Molecular Biosciences
February 21, 2022
10.3389/fmolb.2021.793445
Cited by 19

Related Papers

An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
|Molecular Therapy — Nucleic Acids|2018|211
Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer
|Molecular Cancer|2015|199
A novel strategy for forensic age prediction by DNA methylation and support vector regression model
|Scientific Reports|2015|162
Characterization and identification of long non-coding RNAs based on feature relationship
|Bioinformatics|2019|157
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
|Cancer Letters|2018|144